Refined Genetic Localization for Central Core Disease

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1993 Feb 1

PMID 8430700

Citations 9

Authors

J C Mulley

H M Kozman

H A Phillips

A K Gedeon

J A McCure

D E Iles

R G Gregg

K Hogan

F J Couch

D H Maclennan

Affiliations

Soon will be listed here.

Abstract

Central core disease (CCO) is an autosomal dominant myopathy clinically distinct from malignant hyperthermia (MHS). In a large kindred in which the gene for CCO is segregating, two-point linkage analysis gave a maximum lod score, between the central core disease locus (CCO) and the ryanodine receptor locus (RYR1), of 11.8, with no recombination. Mutation within RYR1 is responsible for MHS, and RYR1 is also a candidate locus for CCO. A combination of physical mapping using a radiation-induced human-hamster hybrid panel and of multipoint linkage analysis using the Centre d'Etude du Polymorphisme Humain families established the marker order and sex-average map distances (in centimorgans) on the background map as D19S75-(5.2)-D19S9-(3.4)-D19S191-(2.2)-RYR1-(1.7)-D19S190-(1.6)-D19S47-(2.0)- CYP2B. Recombination was observed between CCO and the markers flanking RYR1. These linkage data are consistent with the hypothesis that CCO and RYR1 are allelic. The most likely position for CCO is near RYR1, with a multipoint lod score of 11.4, in 19q13.1 between D19S191 and D19S190, within the same interval as MHS (RYR1).

Citing Articles

Crystal structure of diamondback moth ryanodine receptor Repeat34 domain reveals insect-specific phosphorylation sites.

Xu T, Yuchi Z BMC Biol. 2019; 17(1):77.

PMID: 31597572 PMC: 6784350. DOI: 10.1186/s12915-019-0698-5.

[Malignant hyperthermia. The ugly].

Ruffert H, Wehner M, Deutrich C, Olthoff D Anaesthesist. 2007; 56(9):923-9.

PMID: 17565473 DOI: 10.1007/s00101-007-1218-5.

Central core disease.

Jungbluth H Orphanet J Rare Dis. 2007; 2:25.

PMID: 17504518 PMC: 1887524. DOI: 10.1186/1750-1172-2-25.

A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.

Lynch P, Tong J, Lehane M, Mallet A, Giblin L, Heffron J Proc Natl Acad Sci U S A. 1999; 96(7):4164-9.

PMID: 10097181 PMC: 22438. DOI: 10.1073/pnas.96.7.4164.

Genetic analysis of voltage-dependent calcium channels.

Fletcher C, Copeland N, Jenkins N J Bioenerg Biomembr. 1998; 30(4):387-98.

PMID: 9758334 DOI: 10.1023/a:1021993723565.

References

Levitt R, Nouri N, Jedlicka A, MCKUSICK V, Marks A, Shutack J . Evidence for genetic heterogeneity in malignant hyperthermia susceptibility. Genomics. 1991; 11(3):543-7. DOI: 10.1016/0888-7543(91)90061-i. View

Couch F, Hogan K, McCarthy T, Gregg R . Dinucleotide repeat polymorphism at the RYR1 locus (19q13.1). Nucleic Acids Res. 1991; 19(18):5094. PMC: 328839. DOI: 10.1093/nar/19.18.5094. View

Gillard E, Otsu K, Fujii J, Khanna V, De Leon S, Derdemezi J . A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics. 1991; 11(3):751-5. DOI: 10.1016/0888-7543(91)90084-r. View

Iles D, Segers B, de Jong P, ALLEMAN J, Wieringa B . Dinucleotide repeat polymorphism at the D19S191 locus. Nucleic Acids Res. 1992; 20(5):1170. PMC: 312147. View

Deufel T, Golla A, Iles D, Meindl A, Meitinger T, Schindelhauer D . Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet. 1992; 50(6):1151-61. PMC: 1682579. View

Fagerlund T, Islander G, Ranklev E, Harbitz I, HAUGE J, Mokleby E . Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle. Clin Genet. 1992; 41(5):270-2. View

Gillard E, Otsu K, Fujii J, Duff C, De Leon S, Khanna V . Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia. Genomics. 1992; 13(4):1247-54. DOI: 10.1016/0888-7543(92)90042-q. View

Hogan K, Couch F, Powers P, Gregg R . A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia. Anesth Analg. 1992; 75(3):441-8. DOI: 10.1213/00000539-199209000-00022. View

Iles D, Segers B, Heytens L, Sengers R, Wieringa B . High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families. Genomics. 1992; 14(3):749-54. DOI: 10.1016/s0888-7543(05)80179-x. View

10.

Byrne E, Blumbergs P, Hallpike J . Central core disease. Study of a family with five affected generations. J Neurol Sci. 1982; 53(1):77-83. DOI: 10.1016/0022-510x(82)90081-8. View

11.

Lathrop G, Lalouel J . Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet. 1984; 36(2):460-5. PMC: 1684427. View

12.

Lathrop G, Lalouel J, Julier C, Ott J . Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A. 1984; 81(11):3443-6. PMC: 345524. DOI: 10.1073/pnas.81.11.3443. View

13.

Mulley J, Gedeon A, Thorn K, Bates L, Sutherland G . Linkage and genetic counselling for the fragile X using DNA probes 52A, F9, DX13, and ST14. Am J Med Genet. 1987; 27(2):435-48. DOI: 10.1002/ajmg.1320270222. View

14.

Weber J, May P . Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 1989; 44(3):388-96. PMC: 1715443. View

15.

Maclennan D, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk R . Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 1990; 343(6258):559-61. DOI: 10.1038/343559a0. View

16.

McCarthy T, Healy J, Heffron J, Lehane M, Deufel T, Lehmann-Horn F . Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature. 1990; 343(6258):562-4. DOI: 10.1038/343562a0. View

17.

Weber J, Kappel C, May P, Kwitek A . Dinucleotide repeat polymorphism at the D19S75 locus. Nucleic Acids Res. 1990; 18(15):4639. PMC: 331333. View

18.

Haan E, Freemantle C, McCure J, Friend K, Mulley J . Assignment of the gene for central core disease to chromosome 19. Hum Genet. 1990; 86(2):187-90. DOI: 10.1007/BF00197703. View

19.

Fujii J, Otsu K, Zorzato F, De Leon S, Khanna V, WEILER J . Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science. 1991; 253(5018):448-51. DOI: 10.1126/science.1862346. View

20.

Kausch K, Lehmann-Horn F, Janka M, Wieringa B, Grimm T, Muller C . Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19. Genomics. 1991; 10(3):765-9. DOI: 10.1016/0888-7543(91)90461-m. View